The Korea Times close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Business
  • Tech
  • Bio
  • Companies
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
Entertainment
& Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
Sports
World
  • SCMP
  • Asia
Video
  • Culture
  • People
  • News
Photos
  • Photo News
  • Darkroom
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
Business
  • Tech
  • Bio
  • Companies
Sun, August 14, 2022 | 04:23
Tech
Technology to predict cancer reviewed at forum
Posted : 2022-08-02 14:13
Updated : 2022-08-03 14:28
Print Preview
Font Size Up
Font Size Down
Liquid biopsy technology is offered by Eone Diagnomics Genome Center for predicting cancerous risks in people with the highest precision. Gettyimagesbank
Liquid biopsy technology is offered by Eone Diagnomics Genome Center for predicting cancerous risks in people with the highest precision. Gettyimagesbank

Predictive diagnosis touted as future direction for 'cancer moonshot'

By Ko Dong-hwan

Early detection has been touted as the easiest way to treat cancer. What if there were technologies that could help predict the likelihood of cancer?

Experts gathered at the National Assembly in Seoul, Monday, for a forum aiming to look into a game-changing predictive diagnostic technique against cancer and how it can be applied in today's medical environment.

Titled "Korea Cancer Moonshot," the forum hosted by Rep. Lee Yong-bin from the main opposition Democratic Party of Korea, a former family physician and a member of the National Assembly's Trade, Industry, Energy, SMEs, and Startups Committee, looked into what the liquid biopsy technique developed by genome sequencing research firm Eone Diagnomics Genome Center (EDGC) does, how effective it is in preventing cancer, as well as caveats in making the technique a more common practice in the country's tightly regulated medical environment.

EDGC, headquartered on Incheon's Songdo, has been implementing results of clients' genetic sequencing analysis in a non-intrusive fashion to general medical applications, including family tree discovery and disease prevention, since 2013.

Rep. Lee, in his speech to open the forum at the National Assembly lawmakers' office building, said that for the technique to become more widely used, fundamental infrastructure to enable it in the prediction of diseases at the earliest stages should be compatible with the existing policies and theories that are focused on field operations.

What the forum has shed new light on was OncoCatch ― derived from the word oncology ― the name of EDGC's liquid biopsy technique. The diagnostic technique, using only a single-drop blood sample, can predict which cancers a person is at risk of developing. One of its exclusive advantages over other liquid biopsy techniques is that it can predictively diagnose multiple cancers at once.

"OncoCatch's diagnosis of bowel cancer, lung cancer and breast cancer showed higher precision than that of Grail," EDGC's Chief Technology Officer Lee Sung-hoon said during the forum, referring to a California-based firm considered a leading player in liquid biopsy in the U.S. "We will expand the technique's accuracy to the 10 most common cancers and start researching in the U.S. and Europe. We are also taking steps to get an approval from Korea's Ministry of Food and Drug Safety to commercialize the technique in the country."

Liquid biopsy technology is offered by Eone Diagnomics Genome Center for predicting cancerous risks in people with the highest precision. Gettyimagesbank
Participants from Monday's forum held at the National Assembly discussed prospects and caveats behind implementing liquid biopsy technology as a predictive diagnostic technique against cancer. Fifth from left is EDGC's Chief Technology Officer Lee Sung-hoon. Ninth from left is Harvard Medical School associate professor Towia Libermann who delivered a keynote speech during the forum. Seventh from left is EDGC's co-founder Lee Min-seob. Courtesy of EDGC

Liquid biopsy is non-intrusive as it predictively diagnoses cancerous risks using a sample of blood, saliva or urine. It is more convenient than traditional cancer tests that relied on sampling through an intrusive apparatus. Because cancers are 90 percent treatable if detected early ― in either the first or second stage ― an effective predictive diagnosis is considered as a game-changer.

Cancer prediction became a national focus in the U.S. earlier this year. The White House in February released a statement delivering President Joe Biden's initiative to "reignite the Cancer Moonshot with renewed White House leadership of this effort." Their goals were to reduce the death rate from cancer by at least 50 percent over the next 25 years, and "end cancer as we know it today."

For the technique to become more widely used in Korea, the expensive examination costs must be lowered and the central government has to mitigate related regulations, the forum suggested.

"What had enabled the fast and precise COVID-19 infection tests (at early COVID-19 testing centers set up nationwide) in Korea was the government's mitigation of the existing regulations," said Kim Jong-won, a professor working for Samsung Medical Center in Seoul's Gangnam District. "How much and how fast the government will unlock the latches will determine the future of the technique's application in practice."

Keynote speeches were given at the event by Towia Libermann, an associate professor at Harvard Medical School and Beth Israel Deaconess Medical Center, as well as Lee Min-seob, co-CEO of EDGC and co-founder of Diagnomics in San Diego. The United Arab Emirates' sovereign wealth fund International Holding Company's Chief Scientific Officer Park Min Sung and other medical experts from Korea Society of Health Screening and Promotion also joined the forum.


Emailaoshima11@koreatimes.co.kr Article ListMore articles by this reporter
 
LG
  • Seoul City to retrofit manholes to prevent fatal falls during floods
  • Ruling party politicians' visits to flood-damaged areas cause stir
  • Yoon pardons Samsung chief, other business tycoons to 'overcome economic crisis'
  • Korea lacks data to operate autonomous vehicles
  • Disney beats Netflix in streaming subscribers
  • Lotte Chilsung Beverage CEO's leadership questioned over numerous scandals
  • Why has Apple Pay been unavailable in Korea?
  • Star novelist's 'Harbin' on Korean independence fighter becomes bestseller
  • [Exclusive] KDB accelerates drive to set up new hub in EU
  • Korean 'jang,' Japanese miso soup turn historic animosity into tasty friendship
  • Interactive News
  • With tough love,
  • 'Santa dogs' help rebuild burnt forests in Andong
  • 'Santa dogs' help rebuild burnt forests in Andong
  • A tale of natural wine
    • Death of young webtoon artist sparks controversy over harsh working conditions Death of young webtoon artist sparks controversy over harsh working conditions
    • 'Good Doctor' director to debut Netflix's high-strung suspense series, 'A Model Family' 'Good Doctor' director to debut Netflix's high-strung suspense series, 'A Model Family'
    • Musical 'Kinky Boots' tells people to love themselves as they are Musical 'Kinky Boots' tells people to love themselves as they are
    • Reality shows go abroad again amid eased COVID-19 travel restrictions Reality shows go abroad again amid eased COVID-19 travel restrictions
    • Crime thriller 'Limit' is about mother's quest to save abducted son Crime thriller 'Limit' is about mother's quest to save abducted son
    DARKROOM
    • Ice is melting, land is burning

      Ice is melting, land is burning

    • Tottenham 6-3 Team K League

      Tottenham 6-3 Team K League

    • Afghanistan earthquake killed more than 1,000

      Afghanistan earthquake killed more than 1,000

    • Divided America reacts to overturn of Roe vs. Wade

      Divided America reacts to overturn of Roe vs. Wade

    • Namaste: Yogis to celebrate International Yoga Day

      Namaste: Yogis to celebrate International Yoga Day

    The Korea Times
    CEO & Publisher : Oh Young-jin
    Digital News Email : webmaster@koreatimes.co.kr
    Tel : 02-724-2114
    Online newspaper registration No : 서울,아52844
    Date of registration : 2020.02.05
    Masthead : The Korea Times
    Copyright © koreatimes.co.kr. All rights reserved.
    • About Us
    • Introduction
    • History
    • Location
    • Media Kit
    • Contact Us
    • Products & Service
    • Subscribe
    • E-paper
    • Mobile Service
    • RSS Service
    • Content Sales
    • Policy
    • Privacy Statement
    • Terms of Service
    • 고충처리인
    • Youth Protection Policy
    • Code of Ethics
    • Copyright Policy
    • Family Site
    • Hankook Ilbo
    • Dongwha Group